Insights into the epidemiology and management of lupus nephritis from the US rheumatologist's perspective.
about
Safety, pharmacokinetics and pharmacodynamics of AMG 811, an anti-interferon-γ monoclonal antibody, in SLE subjects without or with lupus nephritisClinical Outcomes Observed among Biopsy Proven Lupus Nephritis Patients Treated with Mycophenolate Mofetil as First-line Therapy.The relationship between cell apoptosis dysfunction and FEN1 E160D mutation in lupus nephritis patients.
P2860
Insights into the epidemiology and management of lupus nephritis from the US rheumatologist's perspective.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Insights into the epidemiology ...... rheumatologist's perspective.
@en
type
label
Insights into the epidemiology ...... rheumatologist's perspective.
@en
prefLabel
Insights into the epidemiology ...... rheumatologist's perspective.
@en
P2860
P1433
P1476
Insights into the epidemiology ...... rheumatologist's perspective.
@en
P2093
Karen H Costenbader
Paul J Hoover
P2860
P304
P356
10.1016/J.KINT.2016.03.042
P407
P577
2016-06-22T00:00:00Z